Skip to main content
Top
Published in: International Journal of Legal Medicine 4/2016

01-07-2016 | Original Article

Development and validation of a solid-phase extraction method using anion exchange sorbent for the analysis of cannabinoids in plasma and serum by gas chromatography-mass spectrometry

Authors: Angela Gasse, Heidi Pfeiffer, Helga Köhler, Jennifer Schürenkamp

Published in: International Journal of Legal Medicine | Issue 4/2016

Login to get access

Abstract

The aim of this work was to develop and validate a solid-phase extraction (SPE) method for the analysis of cannabinoids with emphasis on a very extensive and effective matrix reduction in order to ensure constant good results in selectivity and sensitivity regardless of the applied measuring technology. This was obtained by the use of an anion exchange sorbent (AXS) and the purposive ionic interaction between matrix components and this sorbent material. In a first step, the neutral cannabinoids ∆9-tetrahydrocannabinol (THC) and 11-hydroxy-∆9-tetrahydrocannabinol (11-OH-THC) were eluted, leaving 11-nor-9-carboxy-∆9-tetrahydrocannabinol (THC-COOH) and the main interfering matrix components bound to the AXS. In a second step, exploiting differences in pH and polarity, it was possible to separate matrix components and THC-COOH, thereby yielding a clean elution of THC-COOH into the same collecting tube as THC and 11-OH-THC. Even when using a simple measuring technology like gas chromatography with single quadrupole mass spectrometry, this two-step elution allows for an obvious decrease in number and intensity of matrix interference in the chromatogram. Hence, in both plasma and serum, the AXS extracts resulted in very good selectivity. Limits of detection and limits of quantification were below 0.25 and 0.35 ng/mL for the neutral cannabinoids in both matrices, 2.0 and 3.0 ng/mL in plasma and 1.6 and 3.3 ng/mL in serum for THC-COOH. The recoveries were ≥79.8 % for all analytes. Interday and intraday imprecisions ranged from 0.8 to 6.1 % relative standard deviation, and accuracy bias ranged from −12.6 to 3.6 %.
Literature
2.
go back to reference Huestis MA, Barnes A, Smith ML (2005) Estimating the time of last cannabis use from plasma Δ9-tetrahydrocannabinol and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol concentrations. Clin Chem 51:2289–2295CrossRef Huestis MA, Barnes A, Smith ML (2005) Estimating the time of last cannabis use from plasma Δ9-tetrahydrocannabinol and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol concentrations. Clin Chem 51:2289–2295CrossRef
3.
go back to reference Weinmann W, Goerner M, Vogt S, Goerke R, Pollak S (2001) Fast confirmation of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol (THC-COOH) in urine by LC/MS/MS using negative atmospheric-pressure chemical ionisation (APCI). Forensic Sci Int 121:103–107CrossRef Weinmann W, Goerner M, Vogt S, Goerke R, Pollak S (2001) Fast confirmation of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol (THC-COOH) in urine by LC/MS/MS using negative atmospheric-pressure chemical ionisation (APCI). Forensic Sci Int 121:103–107CrossRef
4.
go back to reference Schürenkamp J, Gasse A, Pfeiffer H, Köhler H (2015) Difficulties arising from new blood collecing tubes for ethanol determination. Toxichem Krimtech 82(Special issue):268–272 Schürenkamp J, Gasse A, Pfeiffer H, Köhler H (2015) Difficulties arising from new blood collecing tubes for ethanol determination. Toxichem Krimtech 82(Special issue):268–272
5.
go back to reference Toennes SW, Kauert GF (2001) Importance of vacutainer selection in forensic toxicological analysis of drugs of abuse. J Anal Toxicol 25:339–343CrossRef Toennes SW, Kauert GF (2001) Importance of vacutainer selection in forensic toxicological analysis of drugs of abuse. J Anal Toxicol 25:339–343CrossRef
6.
go back to reference Fernandez MMR, De Boeck G, Wood M, Lopez-Rivadulla M, Samyn N (2008) Simultaneous analysis of THC and its metabolites in blood using liquid chromatography–tandem mass spectrometry. J Chromatogr, B 875:465–470CrossRef Fernandez MMR, De Boeck G, Wood M, Lopez-Rivadulla M, Samyn N (2008) Simultaneous analysis of THC and its metabolites in blood using liquid chromatography–tandem mass spectrometry. J Chromatogr, B 875:465–470CrossRef
7.
go back to reference Kemp PM, Abukhalaf IK, Manno JE, Manno BR, Alford DD, Abusada GA (1995) Cannabinoids in humans. I. Analysis of Δ9-tetrahydrocannabinol and six metabolites in plasma and urine using GC-MS. J Anal Toxicol 19:285–291CrossRef Kemp PM, Abukhalaf IK, Manno JE, Manno BR, Alford DD, Abusada GA (1995) Cannabinoids in humans. I. Analysis of Δ9-tetrahydrocannabinol and six metabolites in plasma and urine using GC-MS. J Anal Toxicol 19:285–291CrossRef
8.
go back to reference Andrews R, Paterson S (2012) A validated method for the analysis of cannabinoids in post-mortem blood using liquid–liquid extraction and two-dimensional gas chromatography–mass spectrometry. Forensic Sci Int 222:111–117CrossRef Andrews R, Paterson S (2012) A validated method for the analysis of cannabinoids in post-mortem blood using liquid–liquid extraction and two-dimensional gas chromatography–mass spectrometry. Forensic Sci Int 222:111–117CrossRef
9.
go back to reference Steinmeyer S, Bregel D, Warth S, Kraemer T, Moeller MR (2002) Improved and validated method for the determination of Δ9-tetrahydrocannabinol (THC), 11-hydroxy-THC and 11-nor-9-carboxy-THC in serum, and in human liver microsomal preparations using gas chromatography–mass spectrometry. J Chromatogr, B 772:239–248CrossRef Steinmeyer S, Bregel D, Warth S, Kraemer T, Moeller MR (2002) Improved and validated method for the determination of Δ9-tetrahydrocannabinol (THC), 11-hydroxy-THC and 11-nor-9-carboxy-THC in serum, and in human liver microsomal preparations using gas chromatography–mass spectrometry. J Chromatogr, B 772:239–248CrossRef
10.
go back to reference Brenneisen R, Meyer P, Chtioui H, Saugy M, Kamber M (2010) Plasma and urine profiles of Δ9-tetrahydrocannabinol and its metabolites 11-hydroxy-Δ9-tetrahydrocannabinol and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes. Anal Bioanal Chem 396:2493–2502CrossRef Brenneisen R, Meyer P, Chtioui H, Saugy M, Kamber M (2010) Plasma and urine profiles of Δ9-tetrahydrocannabinol and its metabolites 11-hydroxy-Δ9-tetrahydrocannabinol and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes. Anal Bioanal Chem 396:2493–2502CrossRef
11.
go back to reference Ferreirós N, Labocha S, Walter C, Lötsch J, Geisslinger G (2013) Simultaneous and sensitive LC-MS/MS determination of tetrahydrocannabinol and metabolites in human plasma. Anal Bioanal Chem 405:1399–1406CrossRef Ferreirós N, Labocha S, Walter C, Lötsch J, Geisslinger G (2013) Simultaneous and sensitive LC-MS/MS determination of tetrahydrocannabinol and metabolites in human plasma. Anal Bioanal Chem 405:1399–1406CrossRef
12.
go back to reference Maralikova B, Weinmann W (2004) Confirmatory analysis for drugs of abuse in plasma and urine by high-performance liquid chromatography-tandem mass spectrometry with respect to criteria for compound identification. J Chromatogr, B 811:21–30CrossRef Maralikova B, Weinmann W (2004) Confirmatory analysis for drugs of abuse in plasma and urine by high-performance liquid chromatography-tandem mass spectrometry with respect to criteria for compound identification. J Chromatogr, B 811:21–30CrossRef
13.
go back to reference D’Asaro JA (2000) An automated and simultaneous solid-phase extraction of Δ9-tetrahydrocannabinoal and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol from whole blood using the Zymark RapidTrace™ with confirmation and quantitation by GC-EI-MS. J Anal Toxicol 24:289–295CrossRef D’Asaro JA (2000) An automated and simultaneous solid-phase extraction of Δ9-tetrahydrocannabinoal and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol from whole blood using the Zymark RapidTrace™ with confirmation and quantitation by GC-EI-MS. J Anal Toxicol 24:289–295CrossRef
14.
go back to reference Grauwiler SB, Scholer A, Drewe J (2007) Development of a LC/MS/MS method for the analysis of cannabinoids in human EDTA-plasma and urine after small doses of Cannabis sativa extracts. J Chromatogr, B 850:515–522CrossRef Grauwiler SB, Scholer A, Drewe J (2007) Development of a LC/MS/MS method for the analysis of cannabinoids in human EDTA-plasma and urine after small doses of Cannabis sativa extracts. J Chromatogr, B 850:515–522CrossRef
15.
go back to reference Karschner E, Barnes A, Lowe R, Scheidweiler K, Huestis M (2010) Validation of a two-dimensional gas chromatography mass spectrometry method for the simultaneous quantification of cannabidiol, Δ9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC in plasma. Anal Bioanal Chem 397:603–611CrossRef Karschner E, Barnes A, Lowe R, Scheidweiler K, Huestis M (2010) Validation of a two-dimensional gas chromatography mass spectrometry method for the simultaneous quantification of cannabidiol, Δ9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC in plasma. Anal Bioanal Chem 397:603–611CrossRef
16.
go back to reference Lee D, Vandrey R, Milman G, Bergamaschi M, Mendu D, Murray J, Barnes A, Huestis M (2013) Oral fluid/plasma cannabinoid ratios following controlled oral THC and smoked cannabis administration. Anal Bioanal Chem 405:7269–7279CrossRef Lee D, Vandrey R, Milman G, Bergamaschi M, Mendu D, Murray J, Barnes A, Huestis M (2013) Oral fluid/plasma cannabinoid ratios following controlled oral THC and smoked cannabis administration. Anal Bioanal Chem 405:7269–7279CrossRef
17.
go back to reference Lowe RH, Karschner EL, Schwilke EW, Barnes AJ, Huestis MA (2007) Simultaneous quantification of Δ9-tetrahydrocannabinol, 11-hydroxy-Δ9-tetrahydrocannabinol, and 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid in human plasma using two-dimensional gas chromatography, cryofocusing, and electron impact-mass spectrometry. J Chromatogr A 1163:318–327CrossRef Lowe RH, Karschner EL, Schwilke EW, Barnes AJ, Huestis MA (2007) Simultaneous quantification of Δ9-tetrahydrocannabinol, 11-hydroxy-Δ9-tetrahydrocannabinol, and 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid in human plasma using two-dimensional gas chromatography, cryofocusing, and electron impact-mass spectrometry. J Chromatogr A 1163:318–327CrossRef
18.
go back to reference Schwilke EW, Karschner EL, Lowe RH, Gordon AM, Cadet JL, Herning RI, Huestis MA (2009) Intra- and intersubject whole blood/plasma cannabinoid ratios determined by 2-dimensional, electron impact GC-MS with cryofocusing. Clin Chem 55:1188–1195CrossRef Schwilke EW, Karschner EL, Lowe RH, Gordon AM, Cadet JL, Herning RI, Huestis MA (2009) Intra- and intersubject whole blood/plasma cannabinoid ratios determined by 2-dimensional, electron impact GC-MS with cryofocusing. Clin Chem 55:1188–1195CrossRef
19.
go back to reference Teixeira H, Verstraete A, Proença P, Corte-Real F, Monsanto P, Vieira DN (2007) Validated method for the simultaneous determination of Δ9-THC and Δ9-THC-COOH in oral fluid, urine and whole blood using solid-phase extraction and liquid chromatography–mass spectrometry with electrospray ionization. Forensic Sci Int 170:148–155CrossRef Teixeira H, Verstraete A, Proença P, Corte-Real F, Monsanto P, Vieira DN (2007) Validated method for the simultaneous determination of Δ9-THC and Δ9-THC-COOH in oral fluid, urine and whole blood using solid-phase extraction and liquid chromatography–mass spectrometry with electrospray ionization. Forensic Sci Int 170:148–155CrossRef
20.
go back to reference Milman G, Barnes AJ, Lowe RH, Huestis MA (2010) Simultaneous quantification of cannabinoids and metabolites in oral fluid by two-dimensional gas chromatography mass spectrometry. J Chromatogr A 1217:1513–1521CrossRef Milman G, Barnes AJ, Lowe RH, Huestis MA (2010) Simultaneous quantification of cannabinoids and metabolites in oral fluid by two-dimensional gas chromatography mass spectrometry. J Chromatogr A 1217:1513–1521CrossRef
21.
go back to reference Coulter C, Miller E, Crompton K, Moore C (2008) Tetrahydrocannabinol and two of its metabolites in whole blood using liquid chromatography-tandem mass spectrometry. J Anal Toxicol 32:653–658CrossRef Coulter C, Miller E, Crompton K, Moore C (2008) Tetrahydrocannabinol and two of its metabolites in whole blood using liquid chromatography-tandem mass spectrometry. J Anal Toxicol 32:653–658CrossRef
22.
go back to reference Scurlock RD, Ohlson GB, Worthen DK (2006) The detection of Δ9-tetrahydrocannabinol (THC) and 11-nor-9-Carboxy-Δ9-tetrahydrocannabinol (THCA) in whole blood using two-dimensional gas chromatography and El-mass spectrometry. J Anal Toxicol 30:262–266CrossRef Scurlock RD, Ohlson GB, Worthen DK (2006) The detection of Δ9-tetrahydrocannabinol (THC) and 11-nor-9-Carboxy-Δ9-tetrahydrocannabinol (THCA) in whole blood using two-dimensional gas chromatography and El-mass spectrometry. J Anal Toxicol 30:262–266CrossRef
23.
go back to reference Huang W, Moody DE, Andrenyak DM, Smith EK, Foltz RL, Huestis MA, Newton JF (2001) Simultaneous determination of Δ9-tetrahydrocannabinol and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in human plasma by solid-phase extraction and gas chromatography-negative ion chemical ionization-mass spectrometry. J Anal Toxicol 25:531–537CrossRef Huang W, Moody DE, Andrenyak DM, Smith EK, Foltz RL, Huestis MA, Newton JF (2001) Simultaneous determination of Δ9-tetrahydrocannabinol and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in human plasma by solid-phase extraction and gas chromatography-negative ion chemical ionization-mass spectrometry. J Anal Toxicol 25:531–537CrossRef
24.
go back to reference Peters F, Hartung M, Herbold M, Schmitt G, Daldrup T, Mußhoff F (2009) Anhang B zur Richtlinie der GTFCh zur Qualitätsicherung bei forensisch-toxikologischen Untersuchungen: Anforderungen an die Validierung von Analysenmethoden. Toxichem Krimtech 76:185–208 Peters F, Hartung M, Herbold M, Schmitt G, Daldrup T, Mußhoff F (2009) Anhang B zur Richtlinie der GTFCh zur Qualitätsicherung bei forensisch-toxikologischen Untersuchungen: Anforderungen an die Validierung von Analysenmethoden. Toxichem Krimtech 76:185–208
25.
go back to reference Hidvégi E, Somogyi G (2014) Determination of main tetrahydrocannabinoids by GC-MS: impact of protein precipitation by acetonitrile on solid phase extraction of cannabinoids from human serum. Pharmazie 69:417–419PubMed Hidvégi E, Somogyi G (2014) Determination of main tetrahydrocannabinoids by GC-MS: impact of protein precipitation by acetonitrile on solid phase extraction of cannabinoids from human serum. Pharmazie 69:417–419PubMed
26.
go back to reference Mauden M, Skopp G, Mattern M, Aderjan R (2000) GC/MS-Bestimmung von THCCOOH im Serum: Vergleich verschiedener Aufarbeitungsmethoden und Einfluß von THC-COOH-Glucuronid. Blutalkohol 37(1):48–56 Mauden M, Skopp G, Mattern M, Aderjan R (2000) GC/MS-Bestimmung von THCCOOH im Serum: Vergleich verschiedener Aufarbeitungsmethoden und Einfluß von THC-COOH-Glucuronid. Blutalkohol 37(1):48–56
Metadata
Title
Development and validation of a solid-phase extraction method using anion exchange sorbent for the analysis of cannabinoids in plasma and serum by gas chromatography-mass spectrometry
Authors
Angela Gasse
Heidi Pfeiffer
Helga Köhler
Jennifer Schürenkamp
Publication date
01-07-2016
Publisher
Springer Berlin Heidelberg
Published in
International Journal of Legal Medicine / Issue 4/2016
Print ISSN: 0937-9827
Electronic ISSN: 1437-1596
DOI
https://doi.org/10.1007/s00414-016-1368-6

Other articles of this Issue 4/2016

International Journal of Legal Medicine 4/2016 Go to the issue